Search

everythinglearnresearchcommunity

for

Search:↓

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Resistance exercise can reduce muscle protein issues caused by finasteride.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Finasteride doesn't affect ovulation in normal women.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

An extract from Quercus acutissima bark was found to reduce sebum production and block an enzyme linked to acne.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Hair loss in men is common, treatable, but not curable.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Finasteride affects alcohol intake in male mice, possibly due to neurosteroids.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Dutasteride is more efficient than finasteride, but individual results vary.